Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Regulâtornye issledovaniâ i èkspertiza lekarstvennyh sredstv.Open Access

Analysis of Global Patenting Trends in Radiopharmaceutical Industry: Diagnostics, Therapy, and Theranostics

View Full Paper
Ask AI
Bookmark
Share

Authors

MAM. Yu. AnikeevaYAYu. D. AleksandrovYGYu. A. Gorbunova

Discussion

Loading...

Member takes

Overview

Analysis reveals rising patent activity in radiopharmaceuticals, indicating significant global trends and strategies.

Key Points

  • An increase in patent activity after 2018 highlights innovation in radiopharmaceuticals, particularly with 177 Lu and 68 Ga.
  • Diagnostic applications dominate patenting at 43%, followed by theranostics at 34% and treatment at 23%.
  • A comprehensive patent analysis using the Questel Orbit database covered 4,988 patent families over 24 years.
  • Differences in patent strategies between Russian and foreign institutions point to a need for improved patenting approaches in Russia.

Cite This Study

Anikeeva et al. (2025) studied this question.

synapsesocial.com/papers/68c23922b210217d6477b112https://doi.org/10.30895/1991-2919-2025-15-4-377-390
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Industry Sponsorship and Disease Site Focus in Therapeutic Radiopharmaceutical Clinical Trials Over the Past Decade2025
  2. 2Recent Trends in Radiopharmaceuticals: Focused on Drug Delivery to the Targeted Tissues2025
  3. 3Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management2025
  4. 4Regulatory Requirements for Small-Scale Preparation of Radiopharmaceuticals2025
  5. 5The Novel Achievements in Oncological Metabolic Radio-Therapy: Isotope Technologies, Targeted Theranostics, Translational Oncology Research2025